These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 7938924)

  • 1. Combination antibiotic therapy is appropriate for nosocomial pneumonia in the intensive care unit.
    Lynch JP
    Semin Respir Infect; 1993 Dec; 8(4):268-84. PubMed ID: 7938924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monotherapy is appropriate for nosocomial pneumonia in the intensive care unit.
    Arbo MD; Snydman DR
    Semin Respir Infect; 1993 Dec; 8(4):259-67. PubMed ID: 7938923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital-acquired respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors.
    Akova M
    Int J Clin Pract Suppl; 2002 Mar; (125):19-27; discussion 37-9. PubMed ID: 12014853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of severe infections: should one always administer an aminoglycoside?].
    Cometta A; Baumgartner JD
    Schweiz Med Wochenschr Suppl; 1996; 76():28S-33S. PubMed ID: 8677416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenems.
    Kollef MH
    Respir Care; 2004 Dec; 49(12):1530-41. PubMed ID: 15571647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Michalopoulos A; Kasiakou SK; Mastora Z; Rellos K; Kapaskelis AM; Falagas ME
    Crit Care; 2005 Feb; 9(1):R53-9. PubMed ID: 15693967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current guidelines for the treatment of severe pneumonia and sepsis.
    Bodmann KF
    Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial isolates from mechanically ventilated patients with nosocomial pneumonia within intensive care unit of a tertiary care center.
    Nag VL; Ayyagari A; Venkatesh V; Dash NR; Ghar M; Prasad KN
    J Commun Dis; 2005 Dec; 37(4):281-7. PubMed ID: 17278658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit.
    Depuydt PO; Blot SI; Benoit DD; Claeys GW; Verschraegen GL; Vandewoude KH; Vogelaers DP; Decruyenaere JM; Colardyn FA
    Crit Care Med; 2006 Mar; 34(3):653-9. PubMed ID: 16505649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The choice of empirical antibiotic therapy for nosocomial pneumonia.
    Ramirez JA
    J Chemother; 1994 Apr; 6 Suppl 2():47-50. PubMed ID: 7799054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance patterns among selective Gram-negative bacilli from an intensive care unit in Trinidad, West Indies.
    Orrett FA
    Saudi Med J; 2004 Apr; 25(4):478-83. PubMed ID: 15083220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacterial resistance and antimicrobial therapy in respiratory medicine and intensive care].
    Luna CM; Gherardi C; Famiglietti A; Vay C
    Medicina (B Aires); 2001; 61(5 Pt 1):603-13. PubMed ID: 11721330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
    Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL
    Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia.
    Gruson D; Hilbert G; Vargas F; Valentino R; Bui N; Pereyre S; Bebear C; Bebear CM; Gbikpi-Benissan G
    Crit Care Med; 2003 Jul; 31(7):1908-14. PubMed ID: 12847382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should antibiotic combinations be used to treat ventilator-associated pneumonia?
    Eggimann P; Revelly JP
    Semin Respir Crit Care Med; 2006 Feb; 27(1):68-81. PubMed ID: 16508883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nosocomial pneumonia in patients in intensive care units.
    Podnos SD; Toews GB; Pierce AK
    West J Med; 1985 Nov; 143(5):622-7. PubMed ID: 3909641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoglycosides versus beta-lactams in gram-negative pneumonia.
    Collins T; Gerding DN
    Semin Respir Infect; 1991 Sep; 6(3):136-46. PubMed ID: 1754734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the treatment of Pseudomonas aeruginosa pneumonia.
    El Solh AA; Alhajhusain A
    J Antimicrob Chemother; 2009 Aug; 64(2):229-38. PubMed ID: 19520717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.